Efficacy and safety of combination therapy with an α-glucosidase inhibitor and a dipeptidyl peptidase-4 inhibitor in patients with type 2 diabetes mellitus: A systematic review with meta-analysis-Reference-Cited by-同舟云学术

Efficacy and safety of combination therapy with an α-glucosidase inhibitor and a dipeptidyl peptidase-4 inhibitor in patients with type 2 diabetes mellitus: A systematic review with meta-analysis

Published:2017-10-25 Issue:4 Volume:9 Page:893-902
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J Diabetes Investig

Author:

Min Se Hee¹,Yoon Jeong-Hwa²,Hahn Seokyung³,Cho Young Min¹^ORCID

Affiliation:

1. Division of Endocrinology and Metabolism; Department of Internal Medicine; Seoul National University College of Medicine; Seoul Korea

2. Interdisciplinary Program in Medical Informatics; Seoul National University College of Medicine; Seoul Korea

3. Department of Medicine; Seoul National University College of Medicine/Biostatistics Division of Medical Research Collaborating Center; Seoul National University Hospital; Seoul Korea

Funder

Korea Health Technology R&D Project

Ministry of Health & Welfare, Korea

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdi.12754/fullpdf

Reference56 articles.

1. Novel agents for the treatment of type 2 diabetes;DeFronzo;Diabetes Spectr,2014

2. Pharmacodynamics of vildagliptin in patients with type 2 diabetes during OGTT;He;J Clin Pharmacol,2007